DrugsControl Media Services

News Detail

Covid nasal spray reduces viral load by 94% in 24 hours, 99% in 48 hours: Lancet Study (15-07-2022)

New Delhi, 14 July 2022: A nasal spray administered in high-risk adult COVID-19 patients in India reduced viral load by 94 per cent within 24 hours and 99 per cent in 48 hours, according to the results of phase 3 trial of the drug published in The Lancet Regional......
View Details

Source : India TV

Related News